Page last updated: 2024-10-24

carmustine and Dyspnea

carmustine has been researched along with Dyspnea in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"Ten patients developed pulmonary fibrosis after bischloroethylnitrosourea (BCNU) therapy for malignancy."1.26Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU). ( Bartolucci, AA; Durant, JR; Langford, KH; Murad, TM; Norgard, MJ, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durant, JR1
Norgard, MJ1
Murad, TM1
Bartolucci, AA1
Langford, KH1

Other Studies

1 other study available for carmustine and Dyspnea

ArticleYear
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
    Annals of internal medicine, 1979, Volume: 90, Issue:2

    Topics: Adolescent; Adult; Aged; Carmustine; Cough; Dyspnea; Female; Humans; Hypoxia; Lymphoma; Male; Middle

1979